[HTML] Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival
H Koivunoro, L Kankaanranta, T Seppälä… - Radiotherapy and Oncology, 2019
Background and purpose Head and neck squamous cell carcinoma (HNSCC) that
recurs locally is a therapeutic challenge. We investigated the efficacy of boron
neutron capture therapy (BNCT) in the treatment of such patients and the factors …
recurs locally is a therapeutic challenge. We investigated the efficacy of boron
neutron capture therapy (BNCT) in the treatment of such patients and the factors …
 |  |
Gold Nanoclusters as a contrast agent for image-guided surgery of head and neck tumors
C Colombé, X Le Guével, A Martin-Serrano, M Henry… - … , Biology and Medicine, 2019
With the objective to evaluate the potential of ultra-small gold (Au) nanoclusters
(NCs) for optical image-guided surgery, we synthesized and characterized AuNCs
shelled by zwitterionic or pegylated ligands. The toxicity of the different AuNCs was …
(NCs) for optical image-guided surgery, we synthesized and characterized AuNCs
shelled by zwitterionic or pegylated ligands. The toxicity of the different AuNCs was …
| |
Undertreatment of women with locoregionally advanced head and neck cancer
A Park, A Alabaster, H Shen, LK Mell, JA Katzel - Cancer, 2019
Background It is difficult to predict whether a patient with head and neck cancer
(HNC) is more likely to die of the cancer or another comorbidity. Competing event
models can help to identify individual patients or groups of patients who may be …
(HNC) is more likely to die of the cancer or another comorbidity. Competing event
models can help to identify individual patients or groups of patients who may be …
| |
[PDF] Does perioperative oxandrolone improve nutritional status in patients with cachexia related to head and neck carcinoma?
AM Osmolak, CN Klatt‐Cromwell, AM Price… - Laryngoscope Investigative …, 2019
Background Cancer cachexia affects up to over 50% of advanced head and neck
cancer (HNC) patients. To date, the potential utility of anabolic steroids in
perioperative cachectic HNC patients has not been determined. Methods …
cancer (HNC) patients. To date, the potential utility of anabolic steroids in
perioperative cachectic HNC patients has not been determined. Methods …
| |
The impact of the multidisciplinary tumor board on head and neck cancer outcomes
JC Liu, A Kaplon, E Blackman, C Miyamoto, D Savior… - The Laryngoscope, 2019
Objectives/Hypothesis Although the multidisciplinary tumor board (MTB) is accepted
as best practice for the management of head and neck squamous cell carcinoma
(HNSCC), there is limited evidence showing its impact on survival. Our goal was to …
as best practice for the management of head and neck squamous cell carcinoma
(HNSCC), there is limited evidence showing its impact on survival. Our goal was to …
| |
Cisplatin eligibility issues and alternative regimens in locoregionally advanced head and neck cancer: recommendations for clinical practice
P Szturz, V Cristina, RG Herrera Gómez, J Bourhis… - Frontiers in Oncology, 2019
Well-designed randomized trials provide the highest level of scientific evidence to
guide clinical decision making. In chemoradiotherapy of locally advanced squamous
cell carcinoma of the head and neck, data support the use of three cycles of 100 …
guide clinical decision making. In chemoradiotherapy of locally advanced squamous
cell carcinoma of the head and neck, data support the use of three cycles of 100 …
| |
Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach
G Di Credico, V Edefonti, J Polesel, F Pauli, N Torelli… - Oral Oncology, 2019
Objectives This study aimed at re-evaluating the strength and shape of the dose-
response relationship between the combined (or joint) effect of intensity and duration
of cigarette smoking and the risk of head and neck cancer (HNC). We explored this …
response relationship between the combined (or joint) effect of intensity and duration
of cigarette smoking and the risk of head and neck cancer (HNC). We explored this …
| |
Incidence of Micrometastasis and Isolated Tumour Cells in Clinicopathologically Node-Negative Head and Neck Squamous Cell Carcinoma
KS Majumdar, VUS Rao, R Prasad, V Ramaswamy… - Journal of Maxillofacial and …, 2019
Introduction Occult neck node metastasis in head and neck squamous cell
carcinoma (HNSCC) in the form of micrometastasis and isolated tumour cell (ITC)
often goes unnoticed in the routine pathological examination. This limitation can be …
carcinoma (HNSCC) in the form of micrometastasis and isolated tumour cell (ITC)
often goes unnoticed in the routine pathological examination. This limitation can be …
| |
Assessment of the cytotoxic effects of aporphine prototypes on head and neck cancer cells
DM Rodrigues-Junior, NM de Almeida Pontes… - Investigational New Drugs, 2019
Purpose Among alkaloids, abundant secondary metabolites in plants, aporphines
constitute a class of compounds with interesting biological activities, including
anticancer effects. The present study evaluated the anticancer activities of 14 …
constitute a class of compounds with interesting biological activities, including
anticancer effects. The present study evaluated the anticancer activities of 14 …
| |
[HTML] Subsequent thyroid disorders associated with treatment strategy in head and neck cancer patients: a nationwide cohort study
CL Lin, SY Wu, WT Huang, YH Feng, CY Yiu… - BMC Cancer, 2019
We investigated the risk of thyroid disorders, namely hypothyroidism, thyrotoxicosis
and thyroiditis, in head and neck cancer patients undergoing multimodal treatment. A
cohort study design using Taiwan's National Health Insurance Research Database …
and thyroiditis, in head and neck cancer patients undergoing multimodal treatment. A
cohort study design using Taiwan's National Health Insurance Research Database …
| |
Alexandros Sfakianakis
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182
Anapafseos 5 . Agios Nikolaos
Crete.Greece.72100
2841026182
6948891480
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,